GSP Crop Science Lists at ₹332.30, Up 3.84%

GSP Crop Science Ltd, incorporated in 1985 engaged in manufacturing insecticides, herbicides, fungicides, and plant growth regulators providing crop protection solutions through formulations and technicals serving customers across 20 states in India and 37 countries internationally including USA, Brazil, Vietnam, Singapore, UAE, and Australia with 524 registrations, 102 patents granted, and R&D facilities in Kathwada and Odhav employing 1,221 permanent employees, made a modest debut on BSE and NSE on Tuesday, March 24, 2026. The GSP Crop Science share price opened at ₹332.30 representing premium of 3.84% from issue price of ₹320.00, touched high of ₹362.30 (up 13.22%) before trading around ₹330.85 (up 3.39%).

GSP Crop Science Listing Details

GSP Crop Science launched its IPO at ₹320 per share with minimum investment of 46 shares costing ₹14,720 raising ₹400 crore including ₹120 crore from anchor investors. The IPO received moderate response with subscription of 1.64 times - retail investors undersubscribed at 0.42 times, NII at 3.14 times, QIB at 2.66 times.

First-Day Trading Performance

Listing Price: GSP Crop Science stock price opened at ₹332.30 representing premium of 3.84% from issue price, touched high of ₹362.30 (up 13.22%) before retracing to trade around ₹330.85 (up 3.39%), with VWAP at ₹338.52. The modest listing delivered gains for IPO investors with turnover of ₹9.27 crore, traded volume of 2.74 lakh shares, delivery of 52.29%, and market capitalisation of ₹1,539.07 crore against pre-IPO market cap of ₹1,488.60 crore.

Growth Drivers and Challenges

Growth Drivers:

Diversified Portfolio: Comprehensive agrochemical solutions with 395 formulation registrations and 129 technical registrations across insecticides, herbicides, fungicides, and plant growth regulators serving farmers across domestic and international markets spanning 37 countries.

Strong R&D Capabilities: 102 patents granted with 108 applications under process, dedicated R&D facilities in Kathwada and Odhav for developing complex chemistries enabling innovation-driven product development.

Improving Profitability: PAT growing from ₹17.57 crore in FY23 to ₹81.42 crore in FY25, ROE of 15.62%, ROCE of 15.45%, improving PAT margin of 9.56%, EBITDA margin of 16.45%.

Challenges:

Weak Retail Interest: Retail subscription at 0.42x indicating limited retail confidence with issue appearing fully priced at post-IPO P/E of 9.18x in highly competitive and fragmented agrochemical segment.

Revenue Volatility: Top line declining from ₹1,206.05 crore in FY23 to ₹1,158.23 crore in FY24 before recovering to ₹1,301.06 crore in FY25 reflecting price volatility in agrochemical markets.

Seasonal Business: H1 margins may get diluted in second half historically with debt-to-equity at 0.55 and total borrowings of ₹321.13 crore.

Utilisation of IPO Proceeds

Debt Repayment: ₹170.00 crore for repayment or prepayment of outstanding borrowings representing largest allocation strengthening balance sheet.

General Corporate Purposes: ₹50.32 crore for general corporate purposes supporting business operations.

Financial Performance

Revenue: ₹847.61 crore for H1 FY26, ₹1,301.06 crore for FY25, growth from ₹1,158.23 crore in FY24.

Net Profit: ₹81.07 crore for H1 FY26, ₹81.42 crore in FY25, significant growth from ₹55.54 crore in FY24 and ₹17.57 crore in FY23, with post-IPO EPS of ₹21.22 and P/E of 9.18x..

Track the latest listings and upcoming IPOs here.